Post-Bariatric Hypoglycemia (PBH): Diagnostic and Therapeutic Strategies
|
|
- Dominic Shelton
- 5 years ago
- Views:
Transcription
1 Post-Bariatric Hypoglycemia (PBH): Diagnostic and Therapeutic Strategies Mary-Elizabeth Patti MD Investigator and Adult Endocrinologist Research Division Director, Hypoglycemia Clinic Joslin Diabetes Center Associate Professor of Medicine Harvard Medical School
2 DISCLOSURES Collaborative R44 NIH grant: Xeris Pharmaceuticals, Harvard Engineering Supply support: Dexcom, Insulet Investigator-initiated research grant: Medimmune, Janssen Previous site investigator: Xoma Multicenter ARMMS clinical trial: Funding support: NIH U01 Consultant: Eiger Pharmaceuticals
3 Joslin Christopher Mulla Allison Goldfine CRC Nurses & Staff Kathy Foster Lauren Richardson Pam Walcott Patients! Emmy Suhl RD Nicole Patience RD Joanne Rizzotto RD Jonathan Dreyfuss Hui Pan Ping Li Ali Bajwa Ipsa Arora Rohit Kulkarni Susan Bonner-Weir Gordon Weir Franco Folli Stefano La Rosa Thank you to Harvard School of Engineering Eyal Dassau Alejandro Laguna Stamatina Zavitsanou Sunil Deshpande Frank Doyle BIDMC Radiology Elisa Franquet Gerald Kolodny George Watts Surgery David Lautz Jim Moser Other Colleagues Marzieh Salehi UT San Antonio Adrian Vella Mayo Clinic Tracey McLaughlin Stanford University Jens Holst University of Copenhagen Funding NIDDK-SBIR (with Xeris) Dexcom Insulet NIH U01 ARMMS
4 Hypoglycemia is Increasingly Recognized After Bariatric Surgery Normal Anatomy Roux-en-Y Gastric Bypass (RYGB) Vertical Sleeve Gastrectomy (VSG) Fundoplication and Other Upper Gastrointestinal Surgery
5 Post-Bariatric Hypoglycemia (PBH) Hypoglycemia is increasingly recognized in patients following bariatric surgery gastric bypass > sleeve gastrectomy Mild postprandial hypoglycemia can be considered a component of the postprandial dumping syndrome Mild cases responsive to dietary management to limit simple CHO
6 Severe Post-Bariatric Hypoglycemia (PBH) A subset of patients have severe hypoglycemia: Requiring assistance of others Neuroglycopenia: seizures, falls, loss of consciousness, motor vehicle accidents Often hypoglycemia unawareness Job/income loss, cognitive dysfunction, loss of driving, disability Characterized by rapid spike in glucose after meals, excessive GLP1 and insulin secretion, later postprandial hypoglycemia Often require both medical nutrition therapy & multiple medications to achieve safety Therapy focused to reduce glycemic excursions
7 OVERVIEW Clinical presentation of post-bypass hypoglycemia syndrome Diagnostic strategies How can we differentiate whether symptoms are due to hypoglycemia or other conditions in post-bariatric patients? How can we define the underlying cause of hypoglycemia? Current concepts of pathophysiology Practical management strategies
8 Representative Patient History 66 year old female with obesity since adolescence (BMI 48 kg/m2) No personal or family history of DM or hypoglycemia Laparascopic Roux-en-Y gastric bypass without complications Symptoms of dumping syndrome immediately postoperatively, resolved with dietary modification Presented at 24 months postop (BMI 35 kg/m 2, stable) with palpitations, sweating, and confusion Could this be hypoglycemia?
9 Hypoglycemia Symptoms Adrenergic Tremor Palpitations Anxiety Cholinergic Sweating Hunger Paresthesias Neuroglycopenia Impaired cognition Seizures Consciousness These symptoms are often nonspecific! Overlap with dumping syndrome occurring after meals in bariatric patients Consider also: anxiety, cardiovascular disease, orthostatic hypotension
10 Hypoglycemia Symptoms Adrenergic Tremor Palpitations Anxiety Cholinergic Sweating Hunger Paresthesias Neuroglycopenia Impaired cognition Seizures Consciousness Hypoglycemia Unawareness: A Threat to Safety loss of adrenergic or cholinergic warning symptoms abrupt onset of neuroglycopenia can result in serious falls, motor vehicle accidents, seizures, loss of consciousness
11 What is Required to Define Hypoglycemia? A. Low capillary glucose at time of symptoms B. Low plasma glucose at time of symptoms C. Relief of symptoms by raising glucose D. A and C E. B and C Answer: E Defines Whipple s triad Why is plasma glucose required? cold exposure, vasospasm, meter error Allen O. Whipple surgeon
12 Patient History (continued) Presented to clinic for initial appointment Complained about feeling fatigued, slightly confused Venous glucose 34 mg/dl (1.9 mm) Responded within 15 minutes to 15 g CHO Fulfilled Whipple s triad We were lucky! Hypoglycemia confirmed
13 Diagnostic Strategies
14 Clinical Evaluation of Possible PBH History of Episodes Symptoms? Onset? Type of surgery? Weight trajectory? Severity? Neuroglycopenia? Assistance required? Relation to fasting, meals Provocative foods? Nocturnal symptoms? Coexisting medical issues? Meds? Record-keeping can be helpful Food & symptom log Blinded CGM to identify patterns CGM not for diagnosis as less accurate in hypoglycemia range Typical Patterns in PBH More than 1 year after GI surgery 1-3 hours after eating More common after simple CHO Worse with liquids>solids Not when fasting Occasionally: during/after exercise during overnight hours (2-4 AM)
15 The Roller Coaster of Post-Bypass Glycemia Postprandial spikes 70 Some nocturnal lows Postprandial lows Range: ; 15% of readings under 70 (0-25%)
16 Glycemic Patterns in Post-Bariatric Hypoglycemia
17 Glycemic Patterns in Post-Bariatric Hypoglycemia: Response to Mixed Meal during Research Studies Rapid spike after eating Normal fasting glucose Glucose (mg/dl) * * Time (min) Rapid drop after peak Goldfine & Patti, JCEM 2007
18 Which of the following are not typical patterns in PBH? A. Hypoglycemia before breakfast B. Hypoglycemia beginning 6 months after gastric bypass C. Hypoglycemia 2 hours after last meal D. A, B E. All of the above Answer: D If fasting hypoglycemia or shortly after surgery, not typical of PBH consider alterative diagnoses!
19 What other diagnoses shoud we be considering? Insulinoma 22% present with postprandial hypo Inadequate nutrition/weight loss Adrenal insufficiency Autoimmune hypoglycemia Other systemic disease (liver, kidney) Medication effects Alcohol use Comprehensive history, exam, & targeted labs needed!
20 Patient History (continued) Symptoms occur 5 times per week Symptoms typically occur within 1-2 hours after eating More likely to occur after eating simple CHO No symptoms upon awakening in AM Has been using husband s glucometer Most of readings at time of symptoms are mg/dl Occasionally has autonomic symptoms when glucose >200
21 No prior hypoglycemia Weight stable No relevant medications Patient History (continued) No family history of MEN1 components or hypo No alcohol Exam: BMI 34, otherwise normal Fasting labs: glucose 82 mg/dl, cortisol 12 ug/dl, hemoglobin A1c 5.3%
22 What are the Next Best Step(s) in her Evaluation? A. Oral glucose tolerance test B. 72 hour inpatient fasting test C. Mixed meal tolerance test D. Food, symptom, and glucose log E. Venous sample at time of hypoglycemia, if not already obtained Answers: C, D, E
23 Can We Provoke Hypoglycemia? How? Oral glucose tolerance test? Not well-tolerated in post-gi surgery patients Can provoke severe dumping 10% of healthy have glucose <50 mg/dl during GTT, without neuroglycopenia or EEG changes Hypoglycemia during OGTT physiological hypoglycemia! Hogan et al Mayo Clin Proc 1983
24 Can We Provoke Hypoglycemia? How? What about mixed meal tolerance test? Protein, carbohydrate, and fat No standard at present Liquid vs. solid Varying CHO content: g Be prepared! possible severe hypoglycemia requiring assistance Ensure safe testing environment, ability to rescue
25 What is appropriate glucose threshold to define hypoglycemia? NOT symptoms alone nonspecific, can reflect dumping in this population Strict definition best: Plasma glucose <54 mg/dl* (3 mm) at time of neuroglycopenic symptoms Symptoms promptly relieved with oral CHO *Diabetes Care 2017 ADA/EASD recommendations for hypoglycemia definition
26 What about measuring insulin levels? Insulin responses quantified in clinical studies of PBH during prolonged fast: insulin suppressed (<3 uu/ml) Challenges with post-meal hypoglycemia: Rapid increases in insulin levels after meals At time of subsequent hypoglycemia, insulin not suppressed (e.g. >3 uu/ml, or the lower limit of assay) Secretion Clearance time Plasma Insulin
27 When should we do prolonged inpatient fast? A. All patients with PBH with typical symptoms B. Patients who have fasting hypoglycemia C. Patients who have hypoglycemia early after surgery (<6-12 months) D. Never! E. B and C E. We reserve inpatient fasting to rule out insulinoma for those with atypical symptom patterns fasting, early postop, or unresponsive to therapy.
28 Should we do imaging to exclude insulinoma? Rarely Fasting hypoglycemia & nonsuppressed insulin Other atypical clinical features Lack of response to therapy Imaging for insulinoma notoriously challenging Consider CT, MRI, endoscopic ultrasound Very rare need for arteriogram or selective arterial calcium stimulation testing
29 Symptoms Adrenergic, Cholinergic, or Neuroglycopenic Possible Hypoglycemia Glucose Level During Symptoms? <70 mg/dl >70 mg/dl Can hypoglycemia be confirmed at the time of symptoms? Hypoglycemic Sx + neuroglycopenia Documented glc <50 (venous glucose preferred, spontaneous or provoked*) Relief with CHO YES Hypoglycemic Disorder Assess Patterns & Severity,?Neuroglycopenia R/O Other Causes of Hypoglycemia** NO Unlikely Hypoglycemia Consider Dumping Syndrome, CV Disorders Postprandial pattern? >6 mo after surgery? Likely Post-Bariatric Hypoglycemia Syndrome Initial Treatment Nutrition, Acarbose Salehi Patti JCEM 2018 Fasting or nocturnal hypoglycemia? Started < 6 mo after bariatric surgery? Incomplete Response Frequent Neuroglycopenia Atypical symptoms for post-bariatric hypoglycemia! Consider other hypoglycemic disorders Reassess Patterns With Diary/Masked CGM, Consider Further Hormonal Testing***, Additional Meds****
30 OVERVIEW Clinical presentation of post-bypass hypoglycemia syndrome Diagnostic strategies How can we differentiate whether symptoms are due to hypoglycemia or other conditions in post-bariatric patients? How can we define the underlying cause of hypoglycemia? Current concepts of pathophysiology Practical management strategies
31 Altered Glucose Patterns after Mixed Meal in PBH Spike after eating Nonsurgical Normal fasting glucose Nadir Salehi 2014
32 Altered Postprandial Metabolism after Mixed Meal in PBH Spike after eating Insulin Levels Glc Absorption Insulin Secretion GLP-1 Levels Nadir Salehi 2014
33 Roux-en-Y Gastric Bypass (RYGB) Rapid delivery of nutrients to foregut Early & high peak of glucose Postprandial secretion of GLP1 (10x) GLP1R inh Insulin secretion in postprandial state suppression of insulin secretion with hypoglycemia clearance of insulin Other hormones Insulin-independent glucose uptake Neural effects Postprandial Hypoglycemia
34 Role of Altered Counterregulation?
35 Reduced Counterregulatory Responses during Hypoglycemic Clamp after RYGB Glucagon pre post- RYGB Cortisol post- RYGB Epinephrine Norepinephrine post- RYGB post- RYGB Abrahamsson et al Diabetes 2016
36 What About the Pancreas in Severe PBH? Anti-Glucagon Stain CONTROL Patient 1 Patient 2 Patient 3 Partial pancreatectomy for refractory hypoglycemia Not performed any longer as not curative No insulinoma Diffuse increase in islet number Islets of varying size & shape Patti et al Diabetologia, 2005; Service NEJM 2005
37 RYGB: Patients requiring pancreatectomy for severe hypoglycemia (n=6) Controls: Organ donors or benign tumors (n=10) Reubi & Patti, Diabetologia 2010; increased size/number not consistently observed (Butler et al) Islet Size in Some Series of Patients with Severe PBH Anti- Insulin Staining Control Post-RYGB Insulinoma Islet Size (mm2) PBH CON * Islet number per mm2 PBH CON
38 β-cell Mass is Not a Dominant Contributor! PBH is a Functional Disorder, not Anatomic! Acute feeding via G tube into bypassed stomach largely resolves excessive GLP1 and insulin secretion and hypoglycemia Acute inhibition of GLP1 signaling improves hypoglycemia Partial pancreatectomy does not cure hypoglycemia!
39 Both Insulin-Dependent and Independent Mechanisms Contribute to Hypoglycemia Intestinal hormones Bile acids Altered intestinal mucosa Intestinal glucose uptake Altered gut-liver-brain axis Altered counterregulation
40 OVERVIEW Clinical presentation of post-bypass hypoglycemia syndrome Diagnostic strategies How can we differentiate whether symptoms are due to hypoglycemia or other conditions in post-bariatric patients? How can we define the underlying cause of hypoglycemia? Current concepts of pathophysiology Practical management strategies
41 Goals of Therapy Reduce frequency and severity Improve safety Unlikely complete elimination of hypoglycemia
42 Safety: Test glucose before driving, before bed, and in situations where hypoglycemia likely: After meals, after exercise Nocturnal, especially if AM headaches, vivid dreams, sweating Consider diagnostic or personal CGMS to detect trends early and treat before becomes severe, especially in those with unawareness. Family instruction in glucagon use It is effective as therapy! Medical ID Clinical Management Strategies Correct nutrient deficiencies: B12, D, B-complex, Fe, Ca, minerals Cornstarch (grocery, Extend, UCAN) Glucagon Kit
43 All of the following are important options for initial treatment of PBH except A. Eliminate all carbohydrates B. Controlled consumption of low glycemic index carbohydrates C. Acarbose D. Instruction in use of glucagon for family E. Instruction in treating acute hypoglycemia with simple carbohydrates Answer: A. Complete elimination of all carbs may contribute to reduced nutritional status, risk of hypoglycemia during sleep/activity, reduced responsiveness to glucagon.
44 Medical Nutrition Therapy is the Cornerstone of Treatment of PBH Prevention: reduce stimulus for insulin secretion Avoid intake of simple carbohydrates (high GI) Controlled portions of complex carbs (low GI)» Starting point: 30 g/meal, vary by response Not total CHO elimination reduce glycogen stores, reduce responsiveness to glucagon Standard Diet Controlled CHO Diet Reduced glycemic excursions Nielsen 2016
45 10-Point Nutrition Plan for PBH Dietary measures alone are often not sufficient in severely affected patients but remain the cornerstone of therapy! Suhl et al. SOARD 2017
46 Choose Low Glycemic Index CHO (GOOD!) Avoid High Glycemic Index CHO Suhl et al. SOARD 2017
47 Stepped Pharmacology for PBH Acarbose: Disaccharidase inhibitor Aim: slow CHO absorption postprandial glucose spike stimulus for insulin secretion Often limited by abdominal gas Start gradually, increase to maximum 300 mg/day Can be administered only or in higher doses before meal usually producing hypoglycemia May have improved efficacy if taken 15 minutes before eating
48 Effects of Acarbose : Peak Glucose, Nadir Glucose, Insulin Peak, GLP1 Glucose Insulin GLP1 Valderas Obesity Surgery 2012
49 Stepped Pharmacology for PBH Acarbose Octreotide or pasireotide to incretin & insulin secretion options: preprandial SQ and monthly IM 50 μg pre-meal to start Often limited by diarrhea Occasional worsening of hypoglycemia immediately after injection, possibly due to inhibition of glucagon secretion
50 Somatostatin Analogues? Octreotide or pasireotide? Myint 2012 Eur J Endo SSTR1, 2, 3, 5 with pasireotide LJM de Heide SOARD 2017
51 Stepped Pharmacology for PBH Acarbose Octreotide or pasireotide to incretin & insulin secretion options: preprandial SQ and monthly IM 50 μg pre-meal to start Often limited by diarrhea; gallstones Occasional worsening of hypoglycemia immediately after injection, possibly due to inhibition of glucagon secretion Diazoxide to reduce insulin secretion, limited by edema Other - small response to calcium channel blockade, anticholinergics, metformin, GLP1 agonists, glucocorticoids in my experience Consider if severe: G tube feeds into remnant stomach. Reversal of bypass when feasible. NOT pancreatectomy - not curative, not a mass problem
52 G-Tube Delivery of Nutrients into the Bypassed Stomach in PBH Patient Yields Normal Insulin Secretion Oral G-tube Oral G G tube data O G GLP1 Plasma Glucose O GIP O Insulin G O G G Glucagon McLaughlin T JCEM 2010
53 G-Tube Delivery of Nutrients into the Bypassed Stomach in Severe PBH Patients Can Be Therapeutic Oral G-tube Options for chronic Rx: Bolus Overnight Continuous Different formulas & rates Avoid CHO by mouth CHO via G-tube tolerated Limited by quality of life issues McLaughlin T JCEM 2010
54 Not Pancreatectomy! - Symptom Recurrence is Nearly Universal after Partial Pancreatectomy Symptom- Free Survival Median time to recurrence of hypoglycemia 16 mo 64% were post-bariatric No difference in subsets of bariatric, +SACST, pathology Vanderveen et al. Surgery 2010
55 Consider Reversal of Bariatric Surgery for Severe PBH Davis et al, 2018; Arora et al, 2018
56 SUMMARY OF THERAPEUTIC APPROACHES Monitoring Hypo Safety/Education Medical Therapy Dietary Modification Surgical Therapy JCEM review 2018 Salehi Patti 2018
57 Thank You!
Hypoglycemia After Bariatric Surgery: Diagnostic and Therapeutic Strategies
Hypoglycemia After Bariatric Surgery: Diagnostic and Therapeutic Strategies Mary-Elizabeth Patti MD Investigator and Adult Endocrinologist Research Division Director, Hypoglycemia Clinic Joslin Diabetes
More informationDeveloping a Treatment for Post-Bariatric Hypoglycemia. December 9, 2016
Developing a Treatment for Post-Bariatric Hypoglycemia December 9, 2016 Forward-Looking Statements This presentation and the oral commentary contain forward-looking statements that involve substantial
More informationSubcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia
Subcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia C OLLEEN M. CRAIG, M.D. T RACEY L. MC L AUGHLIN, M.D., M.S. Division of Endocrinology, Metabolism & Gerontology Stanford University
More informationEndocrine topic reviews. Artit Sangkakam, MD 19, september 2013
Endocrine topic reviews Artit Sangkakam, MD 19, september 2013 Hypoglycemia in Non-DM Definition In diabetic mellitus : Plasma glucose 70 mg/dl In Non-diabetic mellitus : Plasma glucose 55 mg/dl Normal
More informationHypoglycemia in congenital hyperinsulinism
How a normal body works: Our body is constantly at work. Our cells need a source of energy, and this source of energy is called glucose. The process is quite simple; think of it like an assembly line.
More informationDrs Maaz Sohail, FAU Resident and Bryan Vinik, Endocrinology
Drs Maaz Sohail, FAU Resident and Bryan Vinik, Endocrinology HPI: 75M referred for hypoglycemia with symptoms that started 18 months ago. Patient states that after drinking wine at night he would up confused
More informationAppetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After
Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After Roux-en-Y Gastric Bypass June 2018 How a surgical complication
More informationHypoglycaemic disorders
Hypoglycaemic disorders 1. Hypoglycaemia in patients with diabetes mellitus 2. Hypoglycaemia in non-diabetic patients 3. Clinical, laboratory and imaging diagnosis 4. Case report 5. GLP-1 receptor scintigraphy
More informationDavid Bruyette, DVM, DACVIM Medical Director
VCAWLAspecialty.com David Bruyette, DVM, DACVIM Medical Director The pancreas is made up of endocrine and exocrine tissue. The endocrine pancreas is composed of islets of Langerhans, which make up approximately
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationDiabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs
Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,
More informationManaging Endocrine Related Issues after Bariatric Surgery. Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018
Managing Endocrine Related Issues after Bariatric Surgery Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018 Bariatric Surgery was Associated with Higher Remission Rate than Usual Care 72.3% 38.1%
More informationNormal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),
Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from
More informationViriato Fiallo, MD Ursula McMillian, MD
Viriato Fiallo, MD Ursula McMillian, MD Objectives Define obesity and effects on society and healthcare Define bariatric surgery Discuss recent medical management versus surgery research Evaluate different
More informationIntroduction SHORT COMMUNICATION
Diabetologia (2005) 48: 2236 2240 DOI 10.1007/s00125-005-1933-x SHORT COMMUNICATION M. E. Patti. G. McMahon. E. C. Mun. A. Bitton. J. J. Holst. J. Goldsmith. D. W. Hanto. M. Callery. R. Arky. V. Nose.
More informationSHORT COMMUNICATION. J. C. Reubi & A. Perren & R. Rehmann & B. Waser & E. Christ & M. Callery & A. B. Goldfine & M. E. Patti
Diabetologia (2010) 53:2641 2645 DOI 10.1007/s00125-010-1901-y SHORT COMMUNICATION Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic
More informationPancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4)
Vert Phys PCB3743 Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4) T. Houpt, Ph.D. Anatomy of Digestive System Peristalsis Stomach and Acid Secretion Liver and Bile Secretion Pancreas and pancreatic
More informationBariatric surgery results in sustained weight loss and
DIABETES TECHNOLOGY & THERAPEUTICS Volume 20, Number 2, 2018 ª Mary Ann Liebert, Inc. DOI: 10.1089/dia.2017.0298 ORIGINAL ARTICLE Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm
More informationUniversity of Groningen. Dumping syndrome after esophageal, gastric or bariatric surgery van Beek, A.P.; Emous, M.; Laville, Maurice; Tack, Johannes
University of Groningen Dumping syndrome after esophageal, gastric or bariatric surgery van Beek, A.P.; Emous, M.; Laville, Maurice; Tack, Johannes Published in: Obesity Reviews DOI: 10.1111/obr.12467
More informationTechnique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports
Matthew Bettendorf, MD Essentia Health Duluth Clinic Technique Laparoscopic approach One 12mm port, Four 5mm ports Single staple line with no anastamosis 85% gastrectomy Goal to remove
More informationGoals & Objectives. Diabetes Mellitus
Rudy R. Navarro, M.D., CAQSM Department of Family & Community Medicine UT Health Science Center at San Antonio Goals & Objectives Understand the patterns of glucose utilization during exercise and sporting
More informationTreating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric
Treating Type 2 Diabetes with Bariatric Surgery Number (in Millions) of Persons with Diagnosed Diabetes, United States, 198 25 The number of Americans with diabetes increased from 5.6 to 15.8 million Guilherme
More informationOverview. o Limitations o Normal regulation of blood glucose o Definition o Symptoms o Clinical forms o Pathophysiology o Treatment.
Pål R. Njølstad MD PhD KG Jebsen Center for Diabetes Research University of Bergen, Norway Depertment of Pediatrics Haukeland University Hospital Broad Institute of Harvard & MIT Cambridge, MA, USA Hypoglycemia
More information4/23/2015. Linda Steinkrauss, MSN, PNP. No conflicts of interest
Linda Steinkrauss, MSN, PNP No conflicts of interest 1 5 year old African-American female presented to our Endocrinology Clinic with hypoglycemia Abnormal chromosomes Duplication of 11q13.5-11p14.1 affecting
More informationPostgastrectomy Syndromes
Postgastrectomy Syndromes Postgastrectomy syndromes are iatrogenic conditions that may arise from partial gastrectomies, independent of whether the gastric surgery was initially performed for peptic ulcer
More informationBariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes
Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Results of the STAMPEDE Trial Philip R Schauer, Deepak L Bhatt, John P Kirwan, Kathy Wolski, Stacy A Brethauer,
More informationHypoglycemia. When recognized early, hypoglycemia can be treated successfully.
Hypoglycemia Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized early, hypoglycemia
More informationhypoglycemia after gastric bypass surgery An emerging complication
REVIEW EDUCATIONAL OBJECTIVE: Readers will be alert to the possible complication of hypoglycemia in patients who have undergone bariatric surgery RICHARD MILLSTEIN, DO Division of Endocrinology, Metabolism,
More informationBariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient
Bariatric Surgery Policy Number: Original Effective Date: MM.06.003 09/11/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient;
More informationFirst-in-Class Treatment for Hyperinsulinemic Hypoglycemia. January 31, 2017
358 First-in-Class Treatment for Hyperinsulinemic Hypoglycemia January 31, 2017 Forward-Looking Statement Certain statements contained herein including, but not limited to, expected licensing transactions,
More informationBARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS
BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS George Vl Valsamakis European Scope Fellow Obesity Visiting iti Associate Prof Warwick Medical School Diabetes is an increasing healthcare epidemic throughout
More informationA54-year-old nurse with a long-standing history of. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies
MINI-REVIEW Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies Marzieh Salehi, 1 * Adrian Vella, 2 * Tracey McLaughlin, 3 * and Mary-Elizabeth Patti 4 * 1 Diabetes Division,
More informationOBESITY AND WEIGHT LOSS SURGERY FOR THE PRIMARY CARE PHYSICIAN
OBESITY AND WEIGHT LOSS SURGERY FOR THE PRIMARY CARE PHYSICIAN Nicole Basa, M.D., F.A.C.S., F.A.S.M.B.S Assistant Professor of Surgery Texas A&M Medical School Bariatric Medical Director- Cedar Park Regional
More informationCME Post Test. D. Treatment with insulin E. Age older than 55 years
CME Post Test Translational Endocrinology & Metabolism: Metabolic Surgery Update Please select the best answer to each question on the online answer sheet. Go to http://www.endojournals.org/translational/
More informationObesity and Weight Loss Surgery for the Primary Care Physician
Saturday General Session Obesity and Weight Loss Surgery for the Primary Care Physician Nicole Basa, MD Bariatric and General Surgeon Cedar Park Surgeons, PA Cedar Park, Texas Educational Objectives By
More informationWhat is Metabolic About Metabolic Surgery? The New ADA Recommendations
What is Metabolic About Metabolic Surgery? The New ADA Recommendations Obesity Symposium September 16, 2017 Timothy Howland, MD Lourdes Endocrinology Bariatric from the Greek root bar- ("weight" as in
More informationDiabetes: Inpatient Glucose control
Diabetes: Inpatient Glucose control Leanne Current, PharmD, BCPS This activity is funded through the Medicaid section 1115(a) Demonstration Texas Healthcare Transformation and Quality Improvement Program
More informationSubject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119
Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk
More information9/11/2012. Chapter 11. Learning Objectives. Learning Objectives. Endocrine Emergencies. Differentiate type 1 and type 2 diabetes
Chapter 11 Endocrine Emergencies Learning Objectives Differentiate type 1 and type 2 diabetes Explain roles of glucagon, glycogen, and glucose in hypoglycemia Learning Objectives Discuss following medications
More informationHypoglyceamia and Exercise
Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and
More informationObesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.
Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link
More information7/28/17. Objectives: Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern. Disclaimer:
Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern 29TH ANNUAL TNP CONFERENCE TRANSFORMING HEALTHCARE IN TEXAS SEPTEMBER 8, 2017 AUSTIN, TEXAS Kenneth Lowrance, DNP, APRN, CNS, FNP-BC,
More informationScope. History. History. Incretins. Incretin-based Therapy and DPP-4 Inhibitors
Plasma Glucose (mg/dl) Plasma Insulin (pmol/l) Incretin-based Therapy and Inhibitors Scope Mechanism of action ผศ.ดร.นพ.ว ระเดช พ ศประเสร ฐ สาขาว ชาโภชนว ทยาคล น ก ภาคว ชาอาย รศาสตร คณะแพทยศาสตร มหาว ทยาล
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More information6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle
Bariatric Surgery: What the Primary Care Provider Should Know 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive
More informationType 2 diabetes and metabolic surgery:
Type 2 diabetes and metabolic surgery: Shouldn't we call it again again bariatric? Josep Vidal Obesity Unit. Endocrinology and Nutrition Department Hospital Clínic, University of Barcelona (Spain) What
More informationShort-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes
Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes The Harvard community has made this article openly available. Please share how this access
More informationNational Position Statement
National Position Statement Weight Loss Surgery (Bariatric Surgery) and its Use in Treating Obesity or Treating and Preventing Diabetes Background Approximately twenty five per cent (25%) of Australian
More informationManagement of Type 2 Diabetes
Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity
More information10/28/11. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle
Bariatric Surgery: What the Primary Care Provider Should Know 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive
More informationObjectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT
Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of
More informationEffect of macronutrients and mixed meals on incretin hormone secretion and islet cell function
Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Background. Following meal ingestion, several hormones are released from the gastrointestinal tract. Some
More informationINSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE
INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT
More informationLEARNING OBJECTIVES. Obesity. Obesity. Consequences of Malnutrition in Obesity: Undernutrition Concurrent with Overnutriton. Obesity.
@PhD_Leigh #BariatricSurgery #Nutrition LEARNING OBJECTIVES Consequences of Malnutrition in : Undernutrition Concurrent with Overnutriton Leigh A. Frame, PhD, MHS Program Director in Integrative Medicine,
More informationDiabetic Gastroparesis. Evan M. Klass, MD, FACP February 16, 2017
Diabetic Gastroparesis Evan M. Klass, MD, FACP February 16, 2017 Scope of the problem The disorder can affect any part of the GI tract Although 10-20% of the general population suffer from functional GI
More informationHHS Public Access Author manuscript Obesity (Silver Spring). Author manuscript; available in PMC 2016 May 01.
Prevalence of Hypoglycemic Symptoms after Roux-en-Y Gastric Bypass and Vertical Sleeve Gastrectomy and Associated Risk Factors Clare J. Lee 1, Jeanne M. Clark 2, Michael Schweitzer 3, Thomas Magnuson 3,
More informationMetabolic Syndrome: What s so big about BIG?
Tuesday, 10:00 11:30, A2 Objectives: Notes: Metabolic Syndrome: What s so big about BIG? Patrice Conrad pbconrad1@att.net 1. Identify advances in clinical assessment and management of selected healthcare
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationRebecca Newberry APRN MS CDE
Current Diabetes Medications Nursing Implications and Applications Rebecca Newberry APRN MS CDE Methodist Center for Diabetes and Nutritional Health Disclosures Objectives Speakers Bureaus/Consulting Board
More informationBenefits of Bariatric Surgery
Benefits of Bariatric Surgery Dr Tan Bo Chuan Registrar, Department of Surgery GP Forum 27 May 2017 Improvements of Co-morbidities Type 2 diabetes mellitus Hypertension Hyperlipidemia Degenerative joint
More informationHigh and Low GH: an update of diagnosis and management of GH disorders
High and Low GH: an update of diagnosis and management of GH disorders Georgia Chapter-AACE 2017 Laurence Katznelson, MD Professor of Medicine and Neurosurgery Associate Dean of Graduate Medical Education
More informationHypoglycemia, Sick Days/DKA and Hospitalization
Hypoglycemia, Sick Days/DKA and Hospitalization General survival skills for your client with diabetes at home and in Hospital Diabetes Canada guidelines for your client with diabetes while they are in
More informationInpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy
Inpatient Management of Diabetes Mellitus Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy 2 Disclosure Jessica Garza does not have any actual or potential conflicts of
More informationDiabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel
Diabetes Review October 31, 2012 Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review Learning Objectives: Describe the anatomy and physiology of the pancreas Describe the effects of hormones on the maintenance
More informationManaging Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide)
Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide) INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of
More informationHere are some types of gastric bypass surgery:
Gastric Bypass- Definition By Mayo Clinic staff Weight-loss (bariatric) surgeries change your digestive system, often limiting the amount of food you can eat. These surgeries help you lose weight and can
More informationI. General Considerations
1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis
More informationWeek 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD
Week 3, Lecture 5a Pathophysiology of Diabetes Simin Liu, MD, ScD General Model of Peptide Hormone Action Hormone Plasma Membrane Activated Nucleus Cellular Trafficking Enzymes Inhibited Receptor Effector
More informationPolicy Specific Section: April 14, 1970 June 28, 2013
Medical Policy Bariatric Surgery Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date: April 14, 1970 June 28, 2013 Definitions
More informationDiabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute
Diabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute Disclosure Information Melena D. Bellin Disclosure of Relevant
More informationGastric Emptying Time after Laparoscopic Sleeve Gastrectomy
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 4, Issue 7-2018 Gastric Emptying Time
More informationManaging Acromegaly: Review of Two Cases
Managing Acromegaly: Review of Two Cases INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of patients with acromegaly who have
More informationStandards of Medical Care in Diabetes 2016
Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking
More informationUse of Lanreotide (long acting Somatostatin analogue) in Congenital Hyperinsulinism (CHI)
Use of Lanreotide (long acting Somatostatin analogue) in Congenital Hyperinsulinism (CHI) Dr Pratik Shah Clinical Research fellow in Hyperinsulinism Clinical Molecular Genetics Unit Institute of Child
More informationCurrent Status of Bariatric Surgery in Asia
Emerald hall A, 1:2-1:5, November 7, 213 Current Status of Bariatric Surgery in Asia Go Wakabayashi, MD, PhD, FACS Professor and Chairman Department of Surgery Iwate Medical University Numbers of bariatric
More informationObesity Management in Type 2 Diabetes
Obesity Management in Type 2 Diabetes Clare J. Lee, MD, MHS Assistant Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University Disclosures None Objectives Describe
More informationTreating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition
Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with
More informationAn Introduction to Bariatric Surgery
An Introduction to Bariatric Surgery What is bariatric surgery? Bariatric surgery is a treatment used to help people with obesity manage their health and weight. Why use surgery to manage obesity? Obesity
More informationEndocrinology and VHL: The adrenal and the pancreas
Overview Endocrinology and VHL: The adrenal and the pancreas LAUREN FISHBEIN MD, PHD UNIVERSITY OF COLORADO SCHOOL OF MEDICINE DIVISION OF ENDOCRINOLOGY, METABOLISM AND DIABETES DIVISION OF BIOMEDICAL
More informationCommonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital
Commonly Performed Bariatric Procedures in Singapore Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Scope 1. Introduction 2. Principles of bariatric surgery
More informationManagement of Pancreatic Islet Cell Tumors
Management of Pancreatic Islet Cell Tumors Ravi Dhanisetty, MD November 5, 2009 Morbidity and Mortality Conference Case Presentation 42 yr female with chronic abdominal pain. PMHx: Uterine fibroids Medications:
More informationGut involvement in PoTS an overview
Gut involvement in PoTS an overview Qasim Aziz, PhD, FRCP Centre for Neuroscience and Trauma Wingate Institute of Neurogastroenterology Case Hx * 28 year old lady presents with a long hx of constipation
More informationType 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM
Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes
More informationΑναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς
Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναστασία Θανοπούλου Επίκουρη Καθηγήτρια Β Παθολογικής Κλινικής Πανεπιστημίου Αθηνών Διαβητολογικό Κέντρο, Ιπποκράτειο Νοσοκομείο
More informationUnderstanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus
Chapter 19 Understanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus Raymond G. Lau, Michael Radin, Collin E. Brathwaite and Louis Ragolia Additional information
More informationGut and Brain Connection: A New Look. By William L Wilson, M.D.
Gut and Brain Connection: A New Look By William L Wilson, M.D. Central Nervous System Conscious and unconscious mental processing Monitor internal & external environments Auto-regulatory functions Regulates
More informationDedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden
Managing Diabetes in the Athletic Population Dedicated To Aiden Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson
More informationRISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES
RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet
More informationGastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor
Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution
More informationADVANCE Endpoints. Primary outcome. Secondary outcomes
ADVANCE Trial-NEJM 11,140 type 2 patients with h/o microvascular or macrovascular disease or 1 vascular disease risk factor Control A1c to 6.5% vs standard tx Intensive arm received gliclazide XL 30 to
More informationLiving Well with Diabetes
Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form
More informationDiabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
Diabetes Oral Agents Pharmacology University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 Learning Objectives Understand the role of the utilization of free
More informationGoals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management
The Current State of Surgical Intervention in Management of Morbid Obesity Goals Obesity over the last decade Surgery has become a safer management strategy Surgical options for management 1 Goals Obesity
More informationWhat is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming
The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,
More informationCase Report Laparoscopic Adjustable Gastric Banding and Hypoglycemia
Case Reports in Endocrinology Volume 2013, Article ID 671848, 4 pages http://dx.doi.org/10.1155/2013/671848 Case Report Laparoscopic Adjustable Gastric Banding and Hypoglycemia Sigrid Bairdain, 1 Mark
More informationCommon Diabetes-related Terms
Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes
More informationAdrenal Hormone Mineralocorticoids Aldosterone
Adrenal gland Adrenal Hormone Mineralocorticoids Aldosterone Cortex 80 % Glucocorticoids Cortisol Sex hormones Androgen Medulla 20% Catecholamines E, NE 1 2 Adrenal cortex hormones Glucocorticoid Mineralocorticoids
More informationPancreatitis. Acute Pancreatitis
Pancreatitis Pancreatitis is an inflammation of the pancreas. The pancreas is a large gland behind the stomach and close to the duodenum. The duodenum is the upper part of the small intestine. The pancreas
More informationEffect of Bariatric Surgery on Cardio-Metabolic Outcomes
Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Disclosure Research support from Bariatric Advantage (supplements donated for research study) Anne Schafer, MD Associate Professor of Medicine and
More informationGLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks
GLP-1 Receptor Agonists and SGLT-2 Inhibitors Debbie Hicks Prescribing and Adverse Event reporting information is available at this meeting from the AstraZeneca representative The views expressed by the
More information